On September 2, 2026, Simcere Pharma (02096) spent approximately HK$12.3574 million to buy back 1.053 million shares of the company.
This buyback transaction was disclosed in an official announcement from the pharmaceutical firm, reflecting its ongoing capital management strategy.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.